Dose-Response Model of Coxiella burnetii (Q Fever)

Risk Analysis

Volumn 31, Issue 1, 2011, Pages 120-128

  Tamrakar, Sushil B ^a   Haluska, Anne ^b   Haas, Charles N ^a   Bartrand, Timothy A ^a  

^a Drexel University   (United States)

^b University of Illinois at Urbana Champaign   (United States)

Author keywords

Beta Poisson; Coxiella burnetii; Dose response; Intraperitoneal; Q fever; SCID mice

Indexed keywords

BETA-POISSON; COXIELLA BURNETII; DOSE RESPONSE; INTRAPERITONEAL; Q FEVER; SCID MICE;

ANIMALS; BACTERIA; DISEASES;

MAXIMUM LIKELIHOOD ESTIMATION;

BACTERIAL DISEASE; DOSE-RESPONSE RELATIONSHIP; MAXIMUM LIKELIHOOD ANALYSIS; MORTALITY; POISSON RATIO; PUBLIC HEALTH; RODENT;

ANIMAL; ARTICLE; BACTERIAL LOAD; BIOLOGICAL MODEL; C57BL MOUSE; COXIELLA BURNETII; DISEASE MODEL; GUINEA PIG; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; MICROBIOLOGY; MOUSE; MOUSE MUTANT; PATHOGENICITY; Q FEVER; RISK FACTOR; STATISTICAL MODEL; VIRULENCE;

ANIMALS; BACTERIAL LOAD; COXIELLA BURNETII; DISEASE MODELS, ANIMAL; GUINEA PIGS; HUMANS; INJECTIONS, INTRAPERITONEAL; LIKELIHOOD FUNCTIONS; MICE; MICE, INBRED C57BL; MICE, SCID; MODELS, BIOLOGICAL; Q FEVER; RISK FACTORS; VIRULENCE;

ANIMALIA; COXIELLA BURNETII; MUS; NEGIBACTERIA;

EID: 78650539307     PISSN: 02724332     EISSN: 15396924     Source Type: Journal    
DOI: 10.1111/j.1539-6924.2010.01466.x     Document Type: Article

References (25)

1. Leone M, Honstettre A, Lepidi H, Capo C, Bayard F, Raoult D. Effect of sex on Coxiella burnetii infection: Protective role of 17b-estradiol. Journal of Infectious Diseases, 2004; 189:339-345.
2. Zhang GQ, Samuel JE. Vaccines against Coxiella infection. Expert Review of Vaccines, 2004; 3(5):577-584.
3. Madariaga MG, Rezai K, Trenholme GM, Weinstein RA. Q fever: A biological weapon in your backyard. Lancet Infectious Diseases, 2003; 3:709-721.
4. Parker NR, Barralet JH, Bell AM. Q fever. Lancet; 367(9511):679-688.
5. Stein A, Louveau C, Lepidi H, Ricci F, Baylac P, Davoust B, Raoult D. Q fever pneumonia: Virulence of Coxiella burnetii pathovars in a murine model of aerosol infection. Infection and Immunity, 2005; 73(4):2469-2477.
6. Valencia MCS, Rodriguez CO, Punet OG, Giral IB. Q fever seroprevalence and associated risk factors among students from the Veterinary School of Zaragoza, Spain European Journal of Epidemiology, 2000; 16:469-476.
7. Maurin M, Raoult D. Q fever. Clinical Microbiological Review, 1999; 12(4):518-553.
8. Tissot-Dupont H, Raoult D. Q fever. Infectious Disease Clinics of North America, 2008; 22(3):505-514.
9. Waag DM. Coxiella burnetii: Host and bacterial responses to infection. Vaccine, 2007; 25:7288.
10. Russell-Lodrigue KE, Zhang GQ, McMurray DN, Samuel JE. Clinical and pathologic changes in a guinea pig aerosol challenge model of acute Q fever. Infection and Immunity, 2006; 74(11):6085-6091.
11. Watanabe A, Takahashi H. Diagnosis and treatment of Q fever: Attempts to clarify current problems in Japan. Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases, 2008; 14:1-7.
12. La Scola B, Lepidi H, Raoult D. Pathologic changes during acute Q fever: Influence of the route of infection and inoculum size in infected guinea pigs. Infection and Immunity, 1997; 65(6):2443-2447.
13. Baca OG. Pathogenesis of rickettsial infections emphasis on Q fever. European Journal of Epidemiology, 1991; 7(3):222-228.
14. Andoh M, Naganawa T, Hotta A, Yamaguchi T, Fukushi H, Masegi T, Hirai K. SCID mouse model for lethal Q fever. Infection and Immunity, 2003; 71(8):4717-4723.
15. Scott G, Williams JC, Stephenson EH. Animals model in Q fever: Pathological responses of inbred mice to phase I Coxiella Burnetii. Journal of General Microbiology, 1987; 133(3):691-700.
16. Williams JC, Cantrell JL. Biological and immunological properties of Coxiella burnetii vaccines in C57BL/1OScN endotoxin-nonresponder mice. Infection and Immunity, 1982; 35(3):1091-1102.
17. Tigertt WD, Benenson AS. Studies on Q fever in man. Transactions of the Association of American Physicians, 1956; 69:98-104.
18. Haas CN, Rose JB, Gerba CP. Quantitative Microbial Risk Assessment. New York John Wiley & Sons, Inc., 1999.
19. Teunis PFM, Havelaar AH. The Beta Poisson dose-response model is not a single-hit model. Risk Analysis, 2000; 20(4):513-520.
20. Teunis PFM, Nagelkerke NJD, Haas CN. Dose response models for infectious gastroenteritis. Risk Analysis, 1999; 19(6):1251-1260.
21. Faes C, Geys H, Aerts M, Molenberghs G. Use of fractional polynomials for dose-response modelling and quantitative risk assessment in developmental toxicity studies. Statistical Modeling, 2003; 3(2):109-125.
22. Faes C, Aerts M, Geys H, Molenberghs G. Model averaging using fractional polynomials to estimate a safe level of exposure. Risk Analysis, 2007; 27(1):111-123.
23. López-Vázquez C, Dopazo CP, Olveira JG, Barja JL, Bandín I. Development of a rapid, sensitive and non-lethal diagnostic assay for the detection of viral haemorrhagic septicaemia virus. Journal of Virological Methods, 2006; 133(2):167-174.
24. Moos A, Hackstadt T. Comparative virulence of intra- and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model. Infection and Immunity, 1987; 55(5):1144-1150.
25. Raoult D, Marrie TJ, Mege JL. Natural history and pathophysiology of Q fever. Lancet Infectious Diseases, 2005; 5(4):219-226.